Thursday, 15 October 2026

iberempresa

IBEX 3519.177,70▼ -0,28%EuroStoxx 506168,26▼ -0,36%S&P 5007740,30▲ +0,28%€/$1,1218▲ +0,55%Brent106,03▼ -0,03%Bitcoin73.449▲ +0,80%
Breaking

BTIG

Latest BTIG news

1 article

Vial of medication on legal documents with a judge's gavel beside it, in a dimly lit boardroom

Outlook Therapeutics Faces a Decisive July Between the FDA and Capital Dilution

Outlook Therapeutics faces a crucial July: shareholder meeting for capital increase and FDA decision on its flagship drug. Shares rise 144% in 2026.